hCG for Guinea Pigs: Hormonal Treatment for Ovarian Cysts Explained

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Human chorionic gonadotropin, or hCG, is a prescription hormone sometimes used by exotic-animal veterinarians in female guinea pigs with suspected follicular ovarian cysts. These cysts can produce hormones and may be linked to signs like hair loss over the flanks, nipple crusting, behavior changes, and abdominal enlargement. hCG is not a routine home medication. It is an off-label veterinary treatment that should only be used under your vet's direction.

In guinea pigs, hCG is usually discussed as a medical management option, not a cure-all. A 2025 case series in pet guinea pigs with bilateral non-itchy hair loss used hCG once weekly for 3 weeks and reported clinical improvement in all seven patients, although the ovaries and cysts did not shrink overall on ultrasound. That means your vet may use hCG to improve hormone-related signs even when the cyst itself remains present.

It is also important to know what hCG does not do. Current reviews and reference texts still describe ovariectomy or ovariohysterectomy as the recommended definitive treatment for ovarian cyst disease in guinea pigs, especially when cysts are large, painful, recurrent, or causing broader reproductive tract disease. hCG is best viewed as one option within a larger care plan.

Your vet may consider hCG when a female guinea pig has signs that fit hormone-producing follicular cysts rather than nonfunctional serous cysts. Common reasons include bilateral flank alopecia, crusty or enlarged nipples, behavior changes, reduced appetite, or signs of discomfort that line up with ovarian cyst disease on exam and imaging.

This treatment is often most useful when pet parents want a non-surgical option first, or when anesthesia and abdominal surgery carry added risk because of age, body condition, other illness, or access to specialty care. In those cases, hCG may be used as a trial to see whether hormone-driven signs improve.

That said, hCG is not appropriate for every guinea pig with ovarian cysts. Some cysts are serous cysts or parovarian cysts, which may not respond to hormone therapy. If a guinea pig has marked abdominal distension, severe pain, concurrent uterine disease, or a cyst that is large enough to create pressure on nearby organs, your vet may recommend surgery instead of or before medical management.

Dosing must come from your vet. In the 2025 prospective case series most often cited for guinea pigs, hCG was given at 100 IU/kg subcutaneously once weekly for 3 weeks. That protocol was used in female guinea pigs with bilateral nonpruritic alopecia suspected to be related to follicular cysts. Your vet may adjust the plan based on body weight, ultrasound findings, response to treatment, and whether other reproductive disease is present.

Because guinea pigs are small and sensitive patients, accurate dosing matters. Your vet may prefer to give the injections in the clinic, especially for the first dose, so the team can confirm the dose, monitor for soreness, and teach you what changes to watch for at home. Follow-up usually includes a recheck exam and sometimes repeat ultrasound if signs persist or return.

Do not try to estimate a dose from internet forums or from doses used in dogs, cats, livestock, or people. hCG products come in different concentrations, and dosing errors can happen easily after reconstitution. If your guinea pig misses a scheduled injection, call your vet for the next step rather than doubling the next dose.

Reported side effects in guinea pigs appear limited, but that does not mean the medication is risk-free. In the 2025 case series, one guinea pig had a possible mild injection-site soreness reaction. Because published data are still small, your vet will usually recommend close monitoring after each dose.

Call your vet promptly if you notice worsening appetite, reduced stool output, lethargy, hunched posture, increased abdominal pain, swelling at the injection site, or any sudden decline after treatment. Guinea pigs can hide illness until they are quite sick, so even subtle changes matter.

It is also possible for a guinea pig to seem unchanged after hCG because the cyst type may not be hormone-responsive. Lack of improvement, recurrence of hair loss, or ongoing abdominal enlargement does not always mean the medication was given incorrectly. It may mean your vet needs to reassess the diagnosis, repeat imaging, or discuss a different treatment path.

Published guinea pig-specific interaction data for hCG are limited. In practice, the bigger issue is usually treatment context rather than a long list of known drug conflicts. Your vet should know about every medication and supplement your guinea pig receives, including pain medication, antibiotics, appetite support, gut motility drugs, and any other hormone-based treatment.

hCG may be used alongside supportive care, but your vet will want to avoid overlapping or confusing hormone protocols unless there is a clear reason. For example, some exotic veterinarians may compare hCG with other reproductive hormone options such as GnRH-based therapy, and they may choose one approach over another based on the suspected cyst type and the guinea pig's overall stability.

Before treatment, tell your vet if your guinea pig is pregnant, may be pregnant, has known uterine disease, or has had prior reproductive surgery. Those details can change whether hCG is a reasonable option, whether imaging should be repeated first, and whether surgery may be the safer next step.